| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8219626 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 8 Pages |
Abstract
Concurrent sorafenib with CRT had modest clinical activity with increased gastrointestinal toxicity in localized unresectable pancreatic cancer. Select VEGF-A/VEGF-R2 genotypes were associated with favorable survival.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
E. Gabriela MD, Bryan P. MD, Fatih M. MD, Susan M. PhD, Stephen MD, Cynthia S. MA, John MD, Paul MD, Romnee MD, Erica L. Johnston, A. John RN, Jill RN, Guixue PhD, Safi MD, Patrick J. MD, Kumar MD, Higinia R. MD,